Antimicrobial Susceptibility Testing Solutions

The World Health Organization (WHO) lists antimicrobial resistance among the top 10 threats for global health. Increased use and misuse of antimicrobials, create favorable conditions for microorganisms to develop resistance in humans.

Launch Diagnostics offers both genotypic and phenotypic testing solutions allowing laboratories to provide outstanding patient care.

Phenotypic: Liofilchem complete portfolio

• MIC testing strips
• Discs
• Broth microdilution (ComASP)
• Fosfomycin agar dilution panel 
• Antimicrobial susceptibility testing media

Genotypic: Mikrogen PCR

• MDR Panel 1 for the detection of transmissible resistance genes for New Delhi Metallo-ß-lactamase (NDM), Klebsiella pneumoniae Carbapenemase (KPC) and German Imipenemase (GIM) in Enterobacteriaceae
• MDR Panel 2  for the detection of transmissible resistance genes for the carbapenemases New Delhi Metallo-ß-lactamase (NDM), Klebsiella pneumoniae Carbapenemase (KPC) and Sao Paolo Metallo-ß-lactamase (SPM) in Enterobacteri-aceae.
• MDR Panel 3 for the detection of transmissible resistance genes for Extended Spectrum Beta-Lactamases (ESBL) genes in Enterobacteriaceae.
• MDR Panel 4  for the detection of transmissible resistance genes for carbapenemases Imipenemase (IMP), Verona Integron-encoded Metallo-ß-lactamase (VIM) and Oxa-cillinase variant 48 like (OXA-48-like) in Gram-negative bacteria, specifically Pseudomonadaceae
• MDR Panel 5  for the detection of transmissible resistance genes for the carbapenemases New Delhi Metallo-ß-lactamase (NDM) and Oxacillinase variants 23 (OXA-23-like), 24/40 (OXA-24/40-like), 58 (OXA-58-like) and 51 (OXA-51-like with upstream located ISAba1 element), specifically Acinetobacter baumannii.
• MDR Panel 6 is for the detection of transmissible resistance mechanisms against vancomycin and linezol-id in Enterococcaceae